Landmark Phase 3 Study of Xarelto Plus Aspirin Shows Significant Benefit in Patients with Symptomatic PAD after Lower-Extremity Revascularization

, , , , , , , ,

The Janssen Pharmaceutical Companies of Johnson & Johnson announced the VOYAGER PAD study met its primary efficacy and principal safety endpoints.

Read more
/by

Regeneron’s Evinacumab Effective in Treating Rare, Inherited High-Cholesterol Disease

, , , , , ,

Regeneron Pharmaceuticals announced positive results from the company’s pivotal Phase III clinical trial of evinacumab in homozygous familial hypercholesterolemia (HoFH).

Read more
/by